JPWO2022230491A1 - - Google Patents
Info
- Publication number
- JPWO2022230491A1 JPWO2022230491A1 JP2023517170A JP2023517170A JPWO2022230491A1 JP WO2022230491 A1 JPWO2022230491 A1 JP WO2022230491A1 JP 2023517170 A JP2023517170 A JP 2023517170A JP 2023517170 A JP2023517170 A JP 2023517170A JP WO2022230491 A1 JPWO2022230491 A1 JP WO2022230491A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021074321 | 2021-04-26 | ||
| JP2021074321 | 2021-04-26 | ||
| PCT/JP2022/014246 WO2022230491A1 (ja) | 2021-04-26 | 2022-03-25 | 腎機能の低下抑制又は改善用組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2022230491A1 true JPWO2022230491A1 (https=) | 2022-11-03 |
| JP7764471B2 JP7764471B2 (ja) | 2025-11-05 |
Family
ID=83847930
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023517170A Active JP7764471B2 (ja) | 2021-04-26 | 2022-03-25 | 腎機能の低下抑制又は改善用組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240173298A1 (https=) |
| EP (1) | EP4331581A4 (https=) |
| JP (1) | JP7764471B2 (https=) |
| CN (1) | CN117241796A (https=) |
| AU (1) | AU2022267110A1 (https=) |
| TW (1) | TW202308613A (https=) |
| WO (1) | WO2022230491A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230000829A1 (en) * | 2019-10-28 | 2023-01-05 | Suntory Holdings Limited | Composition for sleep improvement comprising ergothioneine or salt thereof |
| CN121001582A (zh) * | 2023-03-28 | 2025-11-21 | 三得利控股株式会社 | 含有麦角硫因或其盐的用于预防、减轻或改善中暑或脱水症的组合物及用于调节细胞内外水分的组合物 |
| CN120241721A (zh) * | 2025-04-25 | 2025-07-04 | 武汉大学中南医院 | 麦角硫因在制备肾损伤保护药物的应用 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021018774A1 (en) * | 2019-07-26 | 2021-02-04 | Fundació Institut D'investigació Biomèdica De Bellvitge (Idibell) | Ergothioneine, s-methyl-ergothioneine, and uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020110604A1 (en) * | 2000-08-11 | 2002-08-15 | Ashni Naturaceuticals, Inc. | Composition exhibiting synergistic antioxidant activity |
| JP5658479B2 (ja) | 2009-04-27 | 2015-01-28 | 株式会社岩出菌学研究所 | 脂肪減少等の活性を示す組成物 |
| US20120141611A1 (en) * | 2010-12-05 | 2012-06-07 | Oxis International Inc. | Methods and compositions using ergothioneine to treat a variety of health related factors |
| US20140121156A1 (en) * | 2011-06-13 | 2014-05-01 | Entia Biosciences, Inc. | Nutritional approach to the control of anemia, diabetes and other diseases or conditions and prevention of associated comorbid states with the use of ergothioneine |
| CA3122246C (en) * | 2018-12-05 | 2025-06-10 | Celagenex Research (India) Pvt. Ltd. | Synergistic compositions of bioactive agents to optimize cell health |
| CN113308378B (zh) * | 2020-02-26 | 2022-11-29 | 华南农业大学 | 高产麦角硫因的灵芝菌株及其应用 |
-
2022
- 2022-03-25 AU AU2022267110A patent/AU2022267110A1/en active Pending
- 2022-03-25 US US18/552,715 patent/US20240173298A1/en active Pending
- 2022-03-25 CN CN202280030906.0A patent/CN117241796A/zh active Pending
- 2022-03-25 WO PCT/JP2022/014246 patent/WO2022230491A1/ja not_active Ceased
- 2022-03-25 EP EP22795409.6A patent/EP4331581A4/en active Pending
- 2022-03-25 JP JP2023517170A patent/JP7764471B2/ja active Active
- 2022-04-21 TW TW111115150A patent/TW202308613A/zh unknown
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021018774A1 (en) * | 2019-07-26 | 2021-02-04 | Fundació Institut D'investigació Biomèdica De Bellvitge (Idibell) | Ergothioneine, s-methyl-ergothioneine, and uses thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| TW202308613A (zh) | 2023-03-01 |
| JP7764471B2 (ja) | 2025-11-05 |
| WO2022230491A1 (ja) | 2022-11-03 |
| EP4331581A4 (en) | 2025-04-09 |
| AU2022267110A1 (en) | 2023-10-05 |
| US20240173298A1 (en) | 2024-05-30 |
| EP4331581A1 (en) | 2024-03-06 |
| CN117241796A (zh) | 2023-12-15 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240514 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20250520 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250605 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20250930 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20251023 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7764471 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |